Emerging Neurobiology of Antidepressant Treatments

This volume is unique in bringing the exciting range of antidepressant treatment developments together with a focus on their neurobiological mechanisms and how these interact with the known pathophysiology of depression. Current evidence for treatment efficacy is reviewed together with a discussion of where in the management pathway of this common condition, these new approaches might take their place.

List of contents

SSRIs A pharmacological cul-de-sac.- Neurobiology of SSRI withdrawal.- Pramipexole in the treatment of depression.- Opioid mechanisms in the treatment of depression.- Neuropsychological effects of antidepressants-translational studies.- KETAMINE FOR MAJOR DEPRESSIVE DISORDER.- Psilocybin and other classic psychedelics in depression.- Gut-brain axis and antidepressant treatment.- Anti-inflammatory drugs in the treatment of depression.- Mechanisms of TMS in Depression.- Mechanism of action of ECT in depression.- Vagal nerve stimulation in the treatment of depression.

Product details

• Assisted by: Michael Browning (Editor), Philip J. Cowen (Editor), Trevor Sharp (Editor)
• Publisher: Springer, Berlin
• Languages: English
• Product format: Hardback
• Released: 25.07.2024
• EAN: 9783031663550
• ISBN: 978-3-0-3166355-0
• No. of pages: 311
• Dimensions: 155 mm x 21 mm x 235 mm
• Weight: 596 g
• Illustrations: X, 311 p. 100 illus., 30 illus. in color.
• Series: Current Topics in Behavioral Neurosciences
• Subject: Natural sciences, medicine, IT, technology > Medicine > Clinical medicine